Older people who repeatedly took the common painkiller had an increase risk of conditions ranging from heart failure to ...

Novo Nordisk announced on Thursday that a key European Medicines Agency committee has backed a label update for weight-loss ...

The EMA approved a kidney disease–related label expansion for the blockbuster GLP-1 drug after a study showed reduced risk of ...

The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the ...

Patients with early breast cancer who are older may experience high-grade immune-related side effects after receiving immune ...

Nigerian PhD student, Sue Agazie, received a tuition refund from Newcastle University after distress over unpaid fees while ...

Explore the disproportionate burden of chronic kidney disease in the Black community and the need for empowerment and ...

GLP-1 agonists substantially slowed kidney deterioration and failure, independent of diabetes status. The most extensive and ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced interim results from a Phase 1/2a clinical study of ARO-CFB, the company’s investigatio ...

ANSWER: There is at least one long-term danger I know from the long-term use of acetaminophen (Tylenol), and it is kidney ...

Clinicians treating patients with kidney disease must be aware of dental considerations to avoid potentially lethal consequences.